相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility
P-Y Wang et al.
GENE THERAPY (2016)
Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing
Darren Qiancheng Tan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus
Yu Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Norman Woller et al.
MOLECULAR THERAPY (2015)
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
L. Vassilev et al.
ONCOIMMUNOLOGY (2015)
An optimized peptide vaccine strategy capable of inducing multivalent CD8+ T cell responses with potent antitumor effects
Hyun-Il Cho et al.
ONCOIMMUNOLOGY (2015)
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
Gregory K. Friedman et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model
J. J. Ruotsalainen et al.
GENE THERAPY (2015)
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
Jennifer L. Leddon et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5' RNA genome end methodology
S. Israelsson et al.
INVESTIGATIONAL NEW DRUGS (2014)
CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
Margaret Gil et al.
JOURNAL OF IMMUNOLOGY (2014)
Smac mimetics and innate immune stimuli synergize to promote tumor death
Shawn T. Beug et al.
NATURE BIOTECHNOLOGY (2014)
Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
James J. Cody et al.
PLOS ONE (2014)
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
Charles Maisonneuve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Interferons and Their Stimulated Genes in the Tumor Microenvironment
HyeonJoo Cheon et al.
SEMINARS IN ONCOLOGY (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
Pattern-recognition receptors and gastric cancer
Natalia Castano-Rodriguez et al.
FRONTIERS IN IMMUNOLOGY (2014)
Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates
Justin C. Roth et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity
Anne Kleijn et al.
ONCOIMMUNOLOGY (2014)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?
Walter H. Meisen et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis
Susanne Berchtold et al.
JOURNAL OF VIROLOGY (2013)
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
Tooba A. Cheema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy
Yu-Ping Liu et al.
SCIENTIFIC REPORTS (2013)
Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
Wei Zhang et al.
NEOPLASIA (2013)
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines
Byram W. Bridle et al.
ONCOIMMUNOLOGY (2013)
Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth
Nikolai N. Khodarev et al.
CLINICAL CANCER RESEARCH (2012)
Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense
Ibtissam Echchgadda et al.
BMC CANCER (2011)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
I-K Choi et al.
GENE THERAPY (2011)
CXCL10 expressing hematopoietic-derived cells are requisite in defense against HSV-1 infection in the nervous system of CXCL10 deficient mice
Todd R. Wuest et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus
Ilkka Liikanen et al.
MOLECULAR THERAPY (2011)
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy
Vladia Monsurro et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer-Preclinical Background: CTLA-4 and PD-1 Blockade
Jeffrey Weber
SEMINARS IN ONCOLOGY (2010)
Dynamics of central and peripheral immunomodulation in a murine glioma model
Benjamin C. Kennedy et al.
BMC IMMUNOLOGY (2009)
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation
Fabian Benencia et al.
CANCER BIOLOGY & THERAPY (2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system
Manoj Thapa et al.
JOURNAL OF IMMUNOLOGY (2008)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy
Y Ino et al.
CLINICAL CANCER RESEARCH (2006)
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit
KC Lee et al.
GENE THERAPY (2006)
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
E Contardi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model
S Ali et al.
CANCER RESEARCH (2005)
Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis
S Wickham et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12
JN Parker et al.
CANCER GENE THERAPY (2005)
The interface between innate and adaptive immunity
K Hoebe et al.
NATURE IMMUNOLOGY (2004)
Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia
CP Marques et al.
GLIA (2004)
Re-evaluating natural resistance to herpes simplex virus type 1
WP Halford et al.
JOURNAL OF VIROLOGY (2004)
Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function
J Melchjorsen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model
CG Miller et al.
MOLECULAR THERAPY (2003)
Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase
SF Stanziale et al.
SURGERY (2002)
Molecular pathways in virus-induced cytokine production
TH Mogensen et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma
RJ Wong et al.
HUMAN GENE THERAPY (2001)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma
SS Yoon et al.
FASEB JOURNAL (2000)
Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer
JJ Bennett et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2000)
分享论文
